Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

Vaxart launches Phase 2b trial for oral COVID-19 vaccine, comparing to mRNA vaccines. 400-subject sentinel cohort begins, with plans for...
1 day ago
from: Stock Titan

Clinical trial, Vaccine

More about this

- Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
400 subject sentinel portion of Phase 2b study will evaluate the safety, immunogenicity and efficacy of Vaxart's next generation oral pill...
from: Yahoo Finance